CTRP9, the closest paralog of adiponectin, plays a role in controlling lipid metabolism by demonstrating anti-inflammatory and anti-atherosclerotic properties and providing cardioprotective benefits in CAD. This evidence concerns the gene C1QTNF9 and coronary artery disorder.